These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 30381030)

  • 1. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
    He H; Liao X; Yang Q; Liu Y; Peng Y; Zhong H; Yang J; Zhang H; Yu Z; Zuo Y; Guan C; Xu Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818809993. PubMed ID: 30381030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-24-3p promotes cell migration and proliferation in lung cancer by targeting SOX7.
    Yan L; Ma J; Zhu Y; Zan J; Wang Z; Ling L; Li Q; Lv J; Qi S; Cao Y; Liu Y; Cao L; Zhang Y; Qi Z; Nie L
    J Cell Biochem; 2018 May; 119(5):3989-3998. PubMed ID: 29231262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
    Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
    Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
    Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
    Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.
    Han L; Wang W; Ding W; Zhang L
    J Cell Mol Med; 2017 Sep; 21(9):2000-2008. PubMed ID: 28266181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
    Yin Y; Du L; Li X; Zhang X; Gao Y
    J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
    Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
    Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
    Wang LQ; Deng AC; Zhao L; Li Q; Wang M; Zhang Y
    J Biol Regul Homeost Agents; 2019; 33(2):321-330. PubMed ID: 30972994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L; Chen L; Luan Q; Kong Q
    J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
    Zhang Q; Li Q; Xu T; Jiang H; Xu LG
    Oncol Rep; 2016 Jun; 35(6):3541-7. PubMed ID: 27035429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
    Liu YH; Liu JL; Wang Z; Zhu XH; Chen XB; Wang MQ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):622-629. PubMed ID: 30720170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.
    Pu X; Jiang H; Li W; Xu L; Wang L; Shu Y
    Med Sci Monit; 2020 Jan; 26():e918382. PubMed ID: 32004259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
    Liu Z; Liu F; Wang F; Yang X; Guo W
    Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.
    Pan X; Peng G; Liu S; Sun Z; Zou Z; Wu G
    Int J Mol Med; 2015 Aug; 36(2):559-64. PubMed ID: 26081980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.